The Dr. Tyna Show cover image

Microdosing GLP1s Has Gone Mainstream | Quick + Dirty

The Dr. Tyna Show

00:00

Reevaluating Microdosing Semaglutide: Myths and Realities

This chapter explores a recent opinion piece on microdosing Semaglutide for diabetes management, clarifying that it was not designed for weight loss. It emphasizes the need for personalized dosing strategies and warns about the misconceptions regarding its effectiveness in obesity treatment.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner